The prognostic role of disseminated tumor cells detected in peripheral blood and bone marrow of colorectal cancer

Hepato-Gastroenterology

Volumn 59, Issue 119, 2012, Pages 2164-2167

  Wu, Peng ^a   Tang, Ri Ning ^b   Zou, Ji Hong ^b   Wang, Feng Chen ^c  

^a Jiangshu Jiankang Vocational College   (China)

^b MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^c SOUTHEAST UNIVERSITY   (China)

Author keywords

CEA; Colorectal cancer; Disseminated tumor cells; Survivin

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; SURVIVIN;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD SAMPLING; BONE MARROW; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CIRCULATING TUMOR CELL; COLON RESECTION; COLORECTAL CANCER; FEMALE; HUMAN; HUMAN CELL; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECTUM RESECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84872054940     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12539     Document Type: Article

References (22)

1. Saif MW, CHU E: Biology of colorectal cancer. Cancer J 2010; 16:196-201.
2. Vegas H, André T, Bidard FC,Yet al.: Disseminated and circulating tumor cells in gastrointestinal oncology. Bull Cancer 2012; 99:535-544.
3. Yalcin S, Kilickap S, Portakal O,Tet al.: Determination of circulating tumor cells for detection of colorectal cancer progression or recurrence. Hepato-gastroenteroy 2010; 57(104):1395-1398.
4. Tsouma A, Aggeli C, Pissimissis N,Met al.: Circulating tumor cells in colorectal cancer: detection methods and clinical significance. Anticancer Res 2008; 28:3945-3960.
5. Raeisossadati R, Farshchian M, Ganji A,Ret al.: Quantitative analysis of TEM-8 and CEA tumor markers indicating free tumor cells in the peripheral blood of colorectal cancer patients. Int J Colorectal Dis 2011; 26:1265-1270.
6. Shen C, Hu L, Xia L, Li Y: Quantitative real-time RT-PCR detection for survivin, CK20 and CEA in peripheral blood of colorectal cancer patients. Jpn J Clin Oncol 2008; 38:770-776.
7. Xu D, Li XF, Zheng S, Jiang WZ: Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients. J Zhejiang Univ Sci B 2006; 7:445-451.
8. Vlems FA, Diepstra JH, Punt CJ, et al.: Detection of disseminated tumour cells in blood and bone marrow samples of patients undergoing hepatic resection for metastasis of colorectal cancer. Br J Surg 2003; 90:989-995.
9. Smith SD, Wheeler MA, Plescia J, Colberg JW, Weiss RM, Altieri DC: Urine detection of survivin and diagnosis of bladder cancer. JAMA 2001; 285:324-328.
10. Huang P, Wang J, Guo Y, Xie W: Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 2003; 129:192-198.
11. Sadahiro S, Suzuki T, Ishikawa K, et al.: Detection of carcinoembryonic antigen messenger RNA-expressing cells in portal and peripheral blood during surgery does not influence relapse in colorectal cancer. Ann Surg Oncol 2005; 12:988-994.
12. Rahbari NN, Aigner M, Thorlund K, et al.: Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 2010; 138:1714-1726.
13. Flatmark K, Borgen E, Nesland JM, et al.: Disseminated tumour cells as a prognostic biomarker in colorectal cancer. Br J Cancer 2011; 104:1434-1439.
14. Sadahiro S, Suzuki T, Maeda Y, et al.: Detection of carcinoembryonic antigen messenger RNA-expressing cells in peripheral blood 7 days after curative surgery is a novel prognostic factor in colorectal cancer. Ann Surg Oncol 2007; 14:1092-1098.
15. Kawahara H, Watanabe K, Toyama Y, et al.: Determination of circulating tumor cells for prediction of recurrent colorectal cancer progression. Hepato-gastroenterol 2012; 59(119), Epub ahead of print
16. Cheung CH, Cheng L, Chang KY, Chen HH, Chang JY: Investigations of survivin: the past, present and future. Front Biosci 2011; 16:952-961.
17. Lan CC, Wu YK, Lee CH, et al.: Increased survivin mRNA in malignant pleural effusion is significantly correlated with survival. Jpn J Clin Oncol 2010; 40:234-240.
18. Yie SM, Lou B, Ye SR, et al.: Detection of survivin-expressing circulating cancer cells (CCCs) in peripheral blood of patients with gastric and colorectal cancer reveals high risks of relapse. Ann Surg Oncol 2008; 15:3073-3082.
19. Fehm T, Hoffmann O, Aktas B, et al.: Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells. Breast Cancer Res 2009; 11:R59.
20. Hu H, Krasinskas A, Willis J: Perspectives on current tumor-node-metastasis (TNM) staging of cancers of the colon and rectum. Semin Oncol 2011; 38:500-510.
21. Nitsche U, Maak M, Schuster T, et al.: Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collective. Ann Surg 2011; 254:793-800.
22. Simunovic M, Jacob S, Coates AJ, Vogt K, Moran BJ, Heald RJ: Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg 2011; 98:1483-1488.